Trials / Completed
CompletedNCT01415466
Pharmacokinetics and Drug Interaction Study Between Rosuvastatin and CS-866 in Healthy Male Volunteers
A Randomized, Open Label, Multiple-Dose, Cross-over Clinical Study to Investigate Pharmacokinetics and Drug-Drug Interaction Between Rosuvastatin and CS-866 in Healthy Male Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Daewoong Pharmaceutical Co. LTD. · Industry
- Sex
- Male
- Age
- 20 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the pharmacokinetics profile and drug-drug interaction between rosuvastatin and CS-866 in healthy male volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cresto | tablet, 20mg |
| DRUG | Olmetec | tablet, 40mg |
| DRUG | Cresto, Olmetec | tablet, 20mg and 40mg |
Timeline
- Start date
- 2011-08-01
- Primary completion
- 2011-09-01
- Completion
- 2011-10-01
- First posted
- 2011-08-12
- Last updated
- 2012-04-04
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01415466. Inclusion in this directory is not an endorsement.